The variant antibody is with an S27eP mutation (var.5) of h8B8. MAb h8B8-var.5 specifically binds to human CD19, which is useful as a therapeutic agent for treatment of an autoimmune disease, rheumatoid arthritis, lupus, psoriasis, or a bone disease or for tumor treatment.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.